Acute Leukemia French Association Clinical Trials
Sponsors / Acute Leukemia French Association
ClinicalTrials.gov lists 19 trials for which Acute Leukemia French Association is named as lead sponsor. The portfolio currently includes 5 recruiting studies, 1 active non-recruiting studies, and 10 completed studies. 3 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 8,827 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
19
Total Trials
5
Recruiting
1
Other Active
10
Completed
3
Terminated / Withdrawn
8,827
Total Enrollment
Termination reasons: Other67% · Recruitment33%
Recent Terminations
- Acute Myeloid Leukemia"Recommendation of DMC"
- Acute Myeloid Leukemia"no recruitment on time"
- Acute Myeloid Leukemia
Active Trials (1 total)
- AML PHASE2NCT05199051
- NCT06377579
- NCT04777916
- AML, Adult PHASE2NCT06022003
- NCT06263387
- Acute Myeloid Leukemia PHASE2NCT05260528